Explore insights by category
Drug Pipeline Insights Reports | Preparing for the GLP-1 Era | Regulatory updates | Videos | On-demand webinars | Podcasts | View all
Latest featured insights
Article
Two AI experts share insights on how we’re using AI and advanced technology to improve everything from trend prediction to member services.
Article
The move to Maximum Fair Prices for popular drugs will trigger new economic considerations for plan sponsors.
White paper
We examine the impact of carve-out approaches, how these carve-outs work against patient experience and clinical value, and how the integrated Optum Rx approach works better for all stakeholders.
Article
There are many misconceptions of pharmacy benefit managers (PBMs) and their services. Here are the facts.
Drug Pipeline Insights Reports
Report
This edition of Notable New Drugs includes another oral GLP-1, the first preventative treatment for COVID-19 and the most effective oral drug for plaque psoriasis.
Report
This edition of Notable New Drugs includes first once-weekly insulin, new psoriatic arthritis treatment and first oral treatment for allergic reactions
Report
Explore 3 new drugs for chronic conditions including obesity, severe asthma and hives (also known as urticaria).
Preparing for the GLP-1 Era
Article
New pills and expanded indications are poised to alter the dynamics of GLP-1 costs and treatments.
White paper
Evolving federal policy on popular weight loss medications introduces additional cost and coverage uncertainties.
Article
Hundreds of clinical trials are vetting GLP-1s to treat everything from Alzheimer’s to arthritis. The question is: How will we afford it?
Latest podcasts
Podcast
Listen to our resident experts discuss critical industry challenges and the solutions you need to control rising drug costs.